The best deals are on TVs and mattresses.

Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive Giovanni Caforio as its ...

This guidance updates and replaces NICE technology appraisal guidance on dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal; TA648). Next review: This guidance will ...

This guidance updates and replaces NICE's highly specialised technologies guidance 12 on cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2, which was available with managed access.

Weak, peeling nails? Meet the nail serum that reforms biters and gel addicts - and keeps selling out Elizabeth Hurley opens up on her experience using £5,000 skincare device and reveals why it's worth ...